HUT43956A - Process for preparing pharmaceuticals - Google Patents

Process for preparing pharmaceuticals

Info

Publication number
HUT43956A
HUT43956A HU872150A HU215087A HUT43956A HU T43956 A HUT43956 A HU T43956A HU 872150 A HU872150 A HU 872150A HU 215087 A HU215087 A HU 215087A HU T43956 A HUT43956 A HU T43956A
Authority
HU
Hungary
Prior art keywords
preparing pharmaceuticals
pharmaceuticals
preparing
Prior art date
Application number
HU872150A
Other languages
English (en)
Other versions
HU198626B (en
Inventor
Jacky Vonderscher
Joachim Franz
Michel Steiger
Karl Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2138/86A external-priority patent/CH667994A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT43956A publication Critical patent/HUT43956A/hu
Publication of HU198626B publication Critical patent/HU198626B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HU872150A 1986-05-27 1987-05-13 Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient HU198626B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
CH214486 1986-05-27

Publications (2)

Publication Number Publication Date
HUT43956A true HUT43956A (en) 1988-01-28
HU198626B HU198626B (en) 1989-11-28

Family

ID=25689611

Family Applications (1)

Application Number Title Priority Date Filing Date
HU872150A HU198626B (en) 1986-05-27 1987-05-13 Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient

Country Status (21)

Country Link
US (1) US5393738A (hu)
KR (1) KR870010870A (hu)
AU (1) AU601740B2 (hu)
BE (1) BE1000722A4 (hu)
CA (1) CA1299495C (hu)
DE (1) DE3716437A1 (hu)
DK (1) DK265587A (hu)
ES (1) ES2008126A6 (hu)
FI (1) FI872313A (hu)
FR (2) FR2599254B1 (hu)
GB (1) GB2190838B (hu)
GR (1) GR870820B (hu)
HU (1) HU198626B (hu)
IL (1) IL82645A0 (hu)
LU (1) LU86901A1 (hu)
MY (1) MY101233A (hu)
NL (1) NL8701143A (hu)
NO (1) NO171484C (hu)
NZ (1) NZ220418A (hu)
SE (1) SE8702188L (hu)
WO (1) WO1987007149A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
FR2668933B1 (fr) * 1990-06-15 1995-05-05 Sandoz Sa Composition pharmaceutique a base de somatostatine.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) * 1999-10-15 2001-04-19 Rainer Rogasch Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
EP1787658B1 (en) 2005-11-10 2012-03-14 CHEMI S.p.A. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
US20100105627A1 (en) * 2008-09-17 2010-04-29 Paul Salama Pharmaceutical compositions and related methods of delivery
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
WO2011084618A2 (en) 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
EP4321213A3 (en) 2014-12-10 2024-05-15 Amryt Endo, Inc. Oral octreotide administered in combination with other therapeutic agents
CN107205948B (zh) 2015-01-29 2021-12-14 诺和诺德股份有限公司 包含glp-1激动剂和肠溶衣的片剂
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1062898A (en) * 1912-12-09 1913-05-27 Fred Drew Automobile.
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4041155A (en) * 1974-10-29 1977-08-09 American Home Products Corporation Long acting somatostatin composition
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) * 1976-08-02 1980-10-28 Vitose Corporation Enhanced protein assimilation with fructose
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
JPS57146723A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS57118509A (en) * 1981-01-14 1982-07-23 Toyo Jozo Co Ltd Novel preparation of high absorbability
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0077354A4 (en) * 1981-04-27 1983-09-30 Baxter Travenol Lab DIALYSIS SOLUTION CONTAINING GLUCOSE, AMINO ACIDS AND INSULIN.
AU558474B2 (en) * 1981-07-17 1987-01-29 Nordisk Insulinlaboratorium A stable aqueous, therapeutic insulin preparation and a process for preparing it
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
WO1985002118A1 (en) * 1983-11-21 1985-05-23 Regents Of The University Of Minnesota A buffered polyol-hormone mixture for use in chronic parenteral hormone administration
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
GR870820B (en) 1987-09-25
MY101233A (en) 1991-08-17
NZ220418A (en) 1990-07-26
FR2630916A1 (fr) 1989-11-10
NO872174L (no) 1987-11-30
AU7336487A (en) 1987-12-03
AU601740B2 (en) 1990-09-20
IL82645A0 (en) 1987-11-30
GB2190838A (en) 1987-12-02
FI872313A (fi) 1987-11-28
FI872313A0 (fi) 1987-05-25
GB2190838B (en) 1990-12-12
HU198626B (en) 1989-11-28
DK265587A (da) 1987-11-28
NO872174D0 (no) 1987-05-25
SE8702188L (sv) 1987-11-28
FR2599254A1 (fr) 1987-12-04
NL8701143A (nl) 1987-12-16
KR870010870A (ko) 1987-12-18
CA1299495C (en) 1992-04-28
BE1000722A4 (fr) 1989-03-21
NO171484C (no) 1993-03-24
LU86901A1 (fr) 1987-12-16
US5393738A (en) 1995-02-28
GB8712193D0 (en) 1987-06-24
SE8702188D0 (sv) 1987-05-25
NO171484B (no) 1992-12-14
FR2630916B1 (fr) 1993-10-22
DK265587D0 (da) 1987-05-25
ES2008126A6 (es) 1989-07-16
FR2599254B1 (fr) 1989-12-01
WO1987007149A1 (en) 1987-12-03
DE3716437A1 (de) 1987-12-03

Similar Documents

Publication Publication Date Title
EG18230A (en) Process for preparing 3-aryloxy-3-substituted propanamines
YU34587A (en) Process for preparing purinic nucleozides
PT85174A (en) Process for preparing azabiciclic compounds
PT86120A (en) Process for preparing n9-cyclopentyl-adenine derivatives
PT85719A (en) Process for preparing 2-amino-ethylamine derivatives
HUT44579A (en) Process for preparing novel compounds and pharmaceuticals comprising them
PT85993A (en) Process for preparing 3-pyrrolidinols
HUT43956A (en) Process for preparing pharmaceuticals
EP0245960A3 (en) Process for preparing n-acyltetrahydroisoquinoline
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
ZA878215B (en) Process for preparing urea
YU119887A (en) Process for preparing dihydroizoquinolines
HUT42766A (en) Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
PT84553A (en) Process for preparing indenopyrimidine derivatives
HUT44238A (en) Process for preparing 1-aryl-5-amino-pyrazole derivatives
HUT40445A (en) Process for preparing 2-bromo-alpha-ergochristine
HUT43022A (en) Process for preparing monochloro-pinacolone
YU213887A (en) Process for preparing new 1-aryloxi-3-amino-2-propanoles
PT86424A (en) Process for preparing substituted tetrahydropyridoindoles
GB8730269D0 (en) Process for preparing 16-dehydro-20-oxipregnane derivatives
HUT43039A (en) Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT42769A (en) Process for preparing pyridazodiazepines
PT84383A (en) Process for preparing substituted pyrimidoindoles
PT84279A (en) Process for preparing 2-aminoacyloxymethyl-2-penem compounds
GR870645B (en) Process for preparing novel ergolene derivatives

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee